{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T18:29:15Z","timestamp":1767205755543,"version":"build-2238731810"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Bullous Pemphigoid (BP) is caused by a predominantly Th2-mediated attack on the basement membrane by the production of anti-BP180 and anti-BP230 antibodies. Malignant tumors can exacerbate immune disorders through a variety of potential pathways, including pro-inflammatory responses in the tumor microenvironment, cross-immune responses induced by tumor-associated antigens, and the lifting of immunosuppressive states and activation of underlying autoimmune responses after surgery. Alopecia Areata (AA) is an autoimmune disease caused by T-lymphocyte-mediated destruction of the immune privilege of the hair follicle, specifically involving the immune axes of Th1, Th2 and Th17. Both AA and BP are associated with dysregulation of cytokines such as IL-4, IL-13, and IL-17. However, the mechanisms underlying the coexistence of the three are unclear, and no cases of their combination have been reported.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>A 67-year-old male patient presented to the clinic complaining of scattered erythema and blisters on the trunk and extremities with marked itching for 4 days. Previously, the patient had undergone surgery for intrahepatic cholangiocarcinoma 10 days earlier. Furthermore, he had developed alopecia areata with the SALT 50 six months earlier and has recovered with white hairs. By combining the patient\u2019s history with his laboratory tests and pathologic examinations, the patient was diagnosed with bullous pemphigoid, intrahepatic cholangiocarcinoma, and alopecia areata. The patient demonstrated normalization of serum tumor markers post-resection of intrahepatic cholangiocarcinoma. Bullous pemphigoid lesions resolved completely with dupilumab-targeted therapy, while alopecia areata exhibited spontaneous remission with full hair regrowth despite no disease-specific treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This case report is the first to present the coexistence of bullous pemphigoid, malignant tumors, and alopecia areata, especially since the patient did not undergo immune medication, such as chemotherapy, which has implications for clinical confrontation with the combined presence of these diseases.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2025.1650253","type":"journal-article","created":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T05:28:48Z","timestamp":1755754128000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Coexistence of bullous pemphigoid, intrahepatic cholangiocarcinoma, and alopecia areata: a case report of multifactorial autoimmunity in a surgical context"],"prefix":"10.3389","volume":"16","author":[{"given":"Shanlin","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dingquan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,8,21]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2025.01.086","article-title":"Bullous pemphigoid: A practical approach to diagnosis and management in the modern era","volume":"92","author":"Powers","year":"2025","journal-title":"J Am Acad Dermatol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"102661","DOI":"10.1016\/j.autrev.2020.102661","article-title":"The role of T cells in pemphigus vulgaris and bullous pemphigoid","volume":"19","author":"Fang","year":"2020","journal-title":"Autoimmun Rev"},{"key":"B3","doi-asserted-by":"publisher","first-page":"189344","DOI":"10.1016\/j.bbcan.2025.189344","article-title":"Interactions between cancer cells and tumor-associated macrophages in tumor microenvironment","volume":"1880","author":"Liu","year":"2025","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.05.006","article-title":"Association of bullous pemphigoid with Malignancy: A systematic review and meta-analysis","volume":"77","author":"Atzmony","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2022.1624","article-title":"Association of bullous pemphigoid with immune checkpoint inhibitor therapy in patients with cancer: A systematic review","volume":"158","author":"Asdourian","year":"2022","journal-title":"JAMA Dermatol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.07.008","article-title":"Bullous disorders associated with anti\u2013PD-1 and anti\u2013PD-L1 therapy: A retrospective analysis evaluating the clinical and histopathologic features, frequency, and impact on cancer therapy","volume":"79","author":"Siegel","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.21836","article-title":"Checkpoint inhibitor-associated bullous cutaneous immune-related adverse events: a multicentre observational study","volume":"187","author":"Kawsar","year":"2022","journal-title":"Br J Dermatol"},{"key":"B8","article-title":"A case of bullous pemphigoid after combined chemotherapy of durvalumab, gemcitabine and cisplatin for intrahepatic cholangiocarcinoma","volume":"52","author":"Hata","year":"2025","journal-title":"Gan To Kagaku Ryoho"},{"key":"B9","doi-asserted-by":"publisher","first-page":"5652","DOI":"10.3390\/ijms25115652","article-title":"Deciphering the complex immunopathogenesis of alopecia areata","volume":"25","author":"\u0160uti\u0107 Udovi\u0107","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1080\/17460441.2024.2409660","article-title":"Innovative strategies for the discovery of new drugs against alopecia areata: taking aim at the immune system","volume":"19","author":"Guo","year":"2024","journal-title":"Expert Opin Drug Discov"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-023-00805-4","article-title":"Comorbid conditions associated with alopecia areata: A systematic review and meta-analysis","volume":"24","author":"Ly","year":"2023","journal-title":"Am J Clin Dermatol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.16420","article-title":"Association between psoriasis and alopecia areata: A systematic review and meta-analysis","volume":"49","author":"Jung","year":"2022","journal-title":"J Dermatol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.07.013","article-title":"Comorbidities in alopecia areata: A systematic review and meta-analysis","volume":"80","author":"Lee","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.jdin.2022.08.025","article-title":"Clinical manifestations of alopecia in autoimmune blistering diseases: A cross-sectional study","volume":"10","author":"Xie","year":"2023","journal-title":"JAAD Int"},{"key":"B15","doi-asserted-by":"publisher","first-page":"001207","DOI":"10.12890\/2019_001207","article-title":"Linagliptin-associated alopecia and bullous pemphigoid","volume":"6","author":"Someili","year":"2019","journal-title":"Eur J Case Rep Intern Med"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.36849\/JDD.6690","article-title":"Rituximab-induced alopecia universalis in a patient with bullous pemphigoid","volume":"21","author":"Puiu","year":"2022","journal-title":"JDDonline - J Drugs Dermatol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.18220","article-title":"Updated S2 K guidelines for the management of bullous pemphigoid initiated by the European Academy of Dermatology and Venereology (EADV)","volume":"36","author":"Borradori","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2017.07.022","article-title":"Cancer and autoimmune diseases","volume":"16","author":"Giat","year":"2017","journal-title":"Autoimmun Rev"},{"key":"B19","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1177\/1203475420943260","article-title":"Cutaneous immune-related adverse events (irAEs) to immune checkpoint inhibitors: A dermatology perspective on management","volume":"25","author":"Muntyanu","year":"2021","journal-title":"J Cutan Med Surg"},{"key":"B20","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s43556-025-00272-9","article-title":"Autoimmune bullous diseases: pathogenesis and clinical management","volume":"6","author":"Feng","year":"2025","journal-title":"Mol Biomed"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-016-0235-z","article-title":"Paraneoplastic pemphigus and autoimmune blistering diseases associated with neoplasm: characteristics, diagnosis, associated neoplasms, proposed pathogenesis, treatment","volume":"18","author":"Kartan","year":"2017","journal-title":"Am J Clin Dermatol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2014.01.011","article-title":"Diagnosis and classification of pemphigus and bullous pemphigoid","volume":"13","author":"Kershenovich","year":"2014","journal-title":"Autoimmun Rev"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.713358\/full","article-title":"Harnessing treg homeostasis to optimize posttransplant immunity: current concepts and future perspectives","volume":"12","author":"Ikegawa","year":"2021","journal-title":"Front Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"749","DOI":"10.3390\/ijms26020749","article-title":"Understanding the intricate pathophysiology of psoriasis and related skin disorders","volume":"26","author":"Orzan","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2312245","DOI":"10.1080\/09546634.2024.2312245","article-title":"Dupliumab therapy for alopecia areata: a case series and review of the literature","volume":"35","author":"Huang","year":"2024","journal-title":"J Dermatol Treat"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e2024270","DOI":"10.5826\/dpc.1404a270","article-title":"Dupilumab and alopecia areata: A possible combined or disturbance therapy? A review of the literature","volume":"14","author":"Starace","year":"2024","journal-title":"Dermatol Pract Concept"},{"key":"B27","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3390\/biom13020388","article-title":"Granzyme B in autoimmune skin disease","volume":"13","author":"Gleave","year":"2023","journal-title":"Biomolecules"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1986.tb02825.x","article-title":"Alopecia areata: alterations in the hair growth cycle and correlation with the follicular pathology","volume":"114","author":"Messenger","year":"1986","journal-title":"Br J Dermatol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1984.tb07461.x","article-title":"Alopecia areata: light and electron microscopic pathology of the regrowing white hair","volume":"110","author":"Messenger","year":"1984","journal-title":"Br J Dermatol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12874660","article-title":"Ultrastructural observations on the hair bulb melanocytes and melanosomes in acute alopecia areata","volume":"94","author":"Tobin","year":"1990","journal-title":"J Invest Dermatol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2000.103909","article-title":"Alopecia areata update","volume":"42","author":"Madani","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.20311","article-title":"Hair regrowth in alopecia areata and re-pigmentation in vitiligo in response to treatment: Commonalities and differences","volume":"39","author":"Y","year":"2025","journal-title":"J Eur Acad Dermatol Venereol: JEADV"}],"updated-by":[{"DOI":"10.3389\/fimmu.2025.1765423","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T00:00:00Z","timestamp":1765929600000}}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1650253\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T15:48:26Z","timestamp":1765986506000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1650253\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,21]]},"references-count":32,"alternative-id":["10.3389\/fimmu.2025.1650253"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1650253","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,21]]},"article-number":"1650253"}}